NDC 62856-212

LEQEMBI

Lecanemab

LEQEMBI is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Eisai Inc.. The primary component is Lecanemab.

• Product ID: 62856-212_aff5d037-645b-4220-95e5-8ac9775f92a0
• NDC: 62856-212
• Product Type: Human Prescription Drug
• Proprietary Name: LEQEMBI
• Generic Name: Lecanemab
• Dosage Form: Injection, Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2023-01-06
• Marketing Category: BLA /
• Application Number: BLA761269
• Labeler Name: Eisai Inc.
• Substance Name: LECANEMAB
• Active Ingredient Strength: 100 mg/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2024-12-31

Packaging

NDC 62856-212-01

1 VIAL, SINGLE-DOSE in 1 CARTON (62856-212-01) > 2 mL in 1 VIAL, SINGLE-DOSE

• Marketing Start Date: 2023-01-06
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "LEQEMBI" or generic name "Lecanemab"

NDC	Brand Name	Generic Name
62856-212	LEQEMBI	lecanemab
62856-215	LEQEMBI	lecanemab